SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bernhard J. Steinhoff, Hajo Hamer, Eugen Trinka, Andreas Schulze-Bonhage, Christian Bien, Thomas Mayer, Christoph Baumgartner, Holger Lerche, Soheyl Noachtar, A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria, Epilepsy Research, 2014, 108, 5, 986

    CrossRef

  2. 2
    Edward Faught, BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy, Expert Opinion on Investigational Drugs, 2014, 23, 1, 107

    CrossRef

  3. 3
    Bernhard J. Steinhoff, Efficacy of perampanel: A review of pooled data, Epilepsia, 2014, 55,
  4. 4
    Bernhard J. Steinhoff, Matthias Bacher, Thomas Bast, Reinhold Kornmeier, Christoph Kurth, Julia Scholly, Anke M. Staack, Ilona Wisniewski, First clinical experiences with perampanel—The Kork experience in 74 patients, Epilepsia, 2014, 55,
  5. 5
    Gregory L. Krauss, Emilio Perucca, Elinor Ben-Menachem, Patrick Kwan, Jerry J. Shih, Jean-François Clément, Xuefeng Wang, Makarand Bagul, Michelle Gee, Jin Zhu, David Squillacote, Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307, Epilepsia, 2014, 55, 7
  6. 6
    Lynn D. Kramer, Andrew Satlin, Gregory L. Krauss, Jacqueline French, Emilio Perucca, Elinor Ben-Menachem, Patrick Kwan, Jerry J. Shih, Antonio Laurenza, Haichen Yang, Jin Zhu, David Squillacote, Perampanel for adjunctive treatment of partial-onset seizures: A pooled dose–response analysis of phase III studies, Epilepsia, 2014, 55, 3
  7. 7
    Valentina Franco, Alfonso Iudice, Elisabetta Grillo, Rita Citraro, Giovambattista De Sarro, Emilio Russo, Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures, Expert Opinion on Pharmacotherapy, 2014, 15, 5, 637

    CrossRef

  8. 8
    Ting Wu, Yoko Nagaya, Takahisa Hanada, Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model, Seizure, 2014,

    CrossRef

  9. 9
    Takahisa Hanada, The discovery and development of perampanel for the treatment of epilepsy, Expert Opinion on Drug Discovery, 2014, 9, 4, 449

    CrossRef

  10. 10
    Kurt Samson, LEGAL-EASE, Neurology Today, 2013, 13, 19, 35

    CrossRef

  11. 11
    Lesley J. Scott, Katherine A. Lyseng-Williamson, Greg L. Plosker, Perampanel: a guide to its use in partial-onset seizures, Drugs & Therapy Perspectives, 2013, 29, 7, 189

    CrossRef

  12. 12
    Gregory L. Krauss, Perampanel: A Selective AMPA Antagonist for Treating Seizures, Epilepsy Currents, 2013, 13, 6, 269

    CrossRef

  13. 13
    Kathrin Schorlemmer, Sebastian Bauer, Marcus Belke, Anke Hermsen, Karl Martin Klein, Philipp S. Reif, Wolfgang H. Oertel, Wolfram S. Kunz, Susanne Knake, Felix Rosenow, Adam Strzelczyk, Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease), Epilepsy & Behavior Case Reports, 2013, 1, 118

    CrossRef

  14. 14
    Seth P. DeVries, Anup D. Patel, Two Patients With a GRIN2A Mutation and Childhood-onset Epilepsy, Pediatric Neurology, 2013, 49, 6, 482

    CrossRef